Home › Compare › CLR vs JNJ

CLR vs JNJ: Dividend Comparison 2026

CLR yields 1.13% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $155.00 in total portfolio value· pulled ahead in Year 9
10 years
CLR
CLR
● Live price
1.13%
Share price
$74.27
Annual div
$0.84
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.9K
Annual income
$0.11
Full CLR calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — CLR vs JNJ

📍 JNJ pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCLRJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CLR + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CLR pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CLR
Annual income on $10K today (after 15% tax)
$96.14/yr
After 10yr DRIP, annual income (after tax)
$0.09/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $703.52/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CLR + JNJ for your $10,000?

CLR: 50%JNJ: 50%
100% JNJ50/50100% CLR
Portfolio after 10yr
$19.9K
Annual income
$413.95/yr
Blended yield
2.08%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CLR right now

CLR
Analyst Ratings
24
Buy
26
Hold
6
Sell
Consensus: Hold
Price Target
$57.85
-22.1% upside vs current
Range: $26.50 — $85.00
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CLR buys
4
JNJ buys
0
PoliticianChamberTickerTypeAmountDate
John Rose🏢 House$CLR▼ Sell$15,001 - $50,0002022-11-29
James Inhofe🏛 Senate$CLR▼ Sell$15,001 - $50,0002019-04-16
James Inhofe🏛 Senate$CLR▼ Sell$15,001 - $50,0002019-04-16
James Inhofe🏛 Senate$CLR▼ Sell$15,001 - $50,0002018-05-29
James Inhofe🏛 Senate$CLR▼ Sell$15,001 - $50,0002018-05-03
James Inhofe🏛 Senate$CLR▼ Sell$15,001 - $50,0002016-06-28
James Inhofe🏛 Senate$CLR▼ Sell$50,001 - $100,0002016-05-12
James Inhofe🏛 Senate$CLR▲ Buy$50,001 - $100,0002016-01-08
James Inhofe🏛 Senate$CLR▼ Sell$15,001 - $50,0002015-08-24
James Inhofe🏛 Senate$CLR▲ Buy$15,001 - $50,0002015-07-20
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCLRJNJ
Forward yield1.13%3.36% ✓
Annual dividend / share$0.84$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR-50%5.8% ✓
Portfolio after 10y$19.9K$20.0K ✓
Annual income after 10y$0.11$827.78 ✓
Total dividends collected$113.00 ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$57.85$228.73 ✓

Year-by-year: CLR vs JNJ ($10,000, DRIP)

YearCLR PortfolioCLR Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,757$56.55$10,676$355.77+$81.00 → CLR
2$11,538$28.42$11,407$389.39+$131.00 → CLR
3$12,360$14.25$12,198$426.53+$162.00 → CLR
4$13,232$7.13$13,056$467.62+$176.00 → CLR
5$14,162$3.57$13,987$513.12+$175.00 → CLR
6$15,155$1.78$14,998$563.56+$157.00 → CLR
7$16,217$0.89$16,098$619.52+$119.00 → CLR
8$17,352$0.45$17,295$681.69+$57.00 → CLR
9← crossover$18,567$0.22$18,599$750.82$32.00 → JNJ
10$19,867$0.11$20,022$827.78$155.00 → JNJ

CLR vs JNJ: Complete Analysis 2026

CLR — Stock

Continental Resources, Inc. explores for, develops, produces, and manages crude oil, natural gas, and related products primarily in the north, south, and east regions of the United States. The company sells its crude oil and natural gas production to energy marketing companies, crude oil refining companies, and natural gas gathering and processing companies. As of December 31, 2021, its proved reserves were 1,645 million barrels of crude oil equivalent (MMBoe) with proved developed reserves of 908 MMBoe. The company was founded in 1967 and is headquartered in Oklahoma City, Oklahoma.

Full CLR Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this CLR vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CLR vs SCHDCLR vs JEPICLR vs OCLR vs KOCLR vs MAINCLR vs ABBVCLR vs MRKCLR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.